首页> 外文期刊>ACS Chemical Biology >Computational Studies Support the Role of the C7-Sibirosamine Sugar of the Pyrrolobenzodiazepine (PBD) Sibiromycin in Transcription Factor Inhibition
【24h】

Computational Studies Support the Role of the C7-Sibirosamine Sugar of the Pyrrolobenzodiazepine (PBD) Sibiromycin in Transcription Factor Inhibition

机译:计算研究支持吡咯并苯二氮杂(PBD)西壁霉素的C7-西壁胺糖在转录因子抑制中的作用。

获取原文
获取原文并翻译 | 示例
       

摘要

The pyrrolo[2,1-c][1,4]benzodiazepines (PBDs) are a group of sequence-selective, DNA minor-groove binding agents that covalently attach to guanine residues. Originally derived from Streptomyces species, a number of naturally occurring PBD monomers exist with varying A-Ring and C2-substituents. One such agent, sibiromycin, is unusual in having a glycosyl residue (sibirosamine) at its A-Ring C7-position. It is the most cytotoxic member of the naturally occurring PBD family and has the highest DNA-binding affinity. Recently, the analogue 9-deoxysibiromyin was produced biosynthetically by Yonemoto and co-workers.1 Differing only in the loss of the A-Ring C9-hydroxyl group, it was reported to have a significantly higher DNA-binding affinity than sibiromycin based on DNA thermal denaturation studies, although these data have since been retracted.2 As deletion of the C9-OH moiety, which points toward the DNA minor groove floor, might intuitively be expected to reduce DNA-binding affinity through the loss of hydrogen bonding, we carried out molecular dynamics simulations on the interaction of both molecules with DNA over a 10 ns time-course in explicit solvent. Our results suggest that the two molecules may differ in their sequence-selectivity and that 9-deoxysibiromycin should have a lower binding affinity for certain sequences of DNA compared to sibiromycin. Our molecular dynamics results indicate that the C7-sibirosamine sugar does not form hydrogen bonding interactions with groups in the DNA minor-groove wall as previously reported, but instead points orthogonally out from the minor groove where it may inhibit the approach of DNA control proteins such as transcription factors. This was confirmed through a docking study involving sibiromycin and the GAL4 transcription factor, and these results could explain the significantly enhanced cytotoxicity of sibiromycin compared to other PBD family members without bulky C7-substituents.
机译:吡咯并[2,1-c] [1,4]苯并二氮杂(PBD)是一组与鸟嘌呤残基共价结合的序列选择性DNA次要凹槽结合剂。最初源自链霉菌种,存在许多天然的PBD单体,具有不同的A环和C2取代基。一种这样的药剂,西伯霉素,在其A环C7位具有糖基残基(西伯胺)是不寻常的。它是天然PBD家族中最具细胞毒性的成员,具有最高的DNA结合亲和力。最近,Yonemoto及其同事通过生物合成方法生产了类似的9-脱氧西伯来霉素。1据报道,仅在A环C9-羟基丢失的情况下,它的结合力明显高于基于DNA的西伯来霉素。热变性研究,尽管这些数据已被撤消。[2]由于直觉上可以预期C9-OH部分的缺失(其指向DNA小沟底)将通过氢键的丧失而降低DNA结合亲和力,因此我们进行了在分子溶剂中,在10 ns的时间过程中,对两种分子与DNA的相互作用进行了分子动力学模拟。我们的结果表明,这两种分子的序列选择性可能不同,并且9-脱氧西伯霉素对某些DNA序列的结合亲和力应低于西伯霉素。我们的分子动力学结果表明,C7-sibirosamine糖不会像先前报道的那样与DNA小槽壁中的基团形成氢键相互作用,而是从小槽中垂直指向,这可能会抑制DNA控制蛋白的途径,例如作为转录因子。通过涉及锡伯霉素和GAL4转录因子的对接研究证实了这一点,这些结果可以解释,与不含大量C7取代基的其他PBD家族成员相比,锡伯霉素的细胞毒性显着增强。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号